Amrize (NYSE:AMRZ) Releases Quarterly Earnings Results, Meets Estimates

Amrize (NYSE:AMRZ) posted its earnings results on Wednesday. The company reported $1.05 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.05, FiscalAI reports. The firm had revenue of $3.77 billion for the quarter. Amrize had a return on equity of 9.96% and a net margin of 9.93%. Amrize’s revenue was up 2.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.98 EPS.

Amrize Stock Performance

Shares of AMRZ stock traded down $0.41 during midday trading on Friday, hitting $41.20. 2,106,762 shares of the company were exchanged, compared to its average volume of 3,434,583. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.73 and a current ratio of 1.10. Amrize has a 52 week low of $35.78 and a 52 week high of $65.94. The firm has a market capitalization of $22.79 billion, a P/E ratio of 18.63, a PEG ratio of 1.42 and a beta of 0.20. The firm’s 50 day moving average price is $39.79 and its two-hundred day moving average price is $50.68.

Amrize Announces Dividend

The firm also recently disclosed a dividend, which will be paid on Wednesday, November 18th. Stockholders of record on Tuesday, November 10th will be given a $0.11 dividend. The ex-dividend date of this dividend is Tuesday, November 10th. Amrize’s dividend payout ratio (DPR) is presently 4.98%.

Insider Buying and Selling at Amrize

In other news, CEO Jan Jenisch purchased 26,000 shares of the stock in a transaction dated Wednesday, September 2nd. The shares were purchased at an average cost of $42.47 per share, with a total value of $1,104,220.00. Following the completion of the acquisition, the chief executive officer owned 1,767,000 shares in the company, valued at $75,044,490. This represents a 1.49% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Stephen S. Clark purchased 5,260 shares of the stock in a transaction on Tuesday, August 11th. The shares were purchased at an average price of $47.31 per share, for a total transaction of $248,850.60. Following the transaction, the insider directly owned 10,637 shares of the company’s stock, valued at approximately $503,236.47. This represents a 97.82% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders purchased 48,983 shares of company stock worth $2,158,755 over the last 90 days. Company insiders own 0.54% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in AMRZ. Amundi increased its holdings in Amrize by 30.9% during the 1st quarter. Amundi now owns 1,654,739 shares of the company’s stock worth $92,698,000 after purchasing an additional 390,750 shares during the period. DJE Kapital AG grew its stake in shares of Amrize by 45.9% in the 1st quarter. DJE Kapital AG now owns 1,113,036 shares of the company’s stock valued at $60,194,000 after buying an additional 350,149 shares during the period. Great Lakes Advisors LLC purchased a new position in shares of Amrize in the second quarter valued at approximately $16,975,000. Ancora Advisors LLC purchased a new stake in Amrize during the second quarter worth approximately $15,112,000. Finally, Assetmark Inc. raised its holdings in shares of Amrize by 18,567.2% in the first quarter. Assetmark Inc. now owns 250,887 shares of the company’s stock valued at $14,055,000 after buying an additional 249,543 shares during the last quarter.

Analysts Set New Price Targets

Several research firms have weighed in on AMRZ. Citigroup dropped their target price on shares of Amrize from $58.00 to $50.00 and set a “buy” rating for the company in a report on Friday, October 2nd. Stephens lowered their price objective on Amrize from $65.00 to $54.00 and set an “overweight” rating for the company in a research note on Wednesday, August 12th. Truist Financial dropped their target price on shares of Amrize from $48.00 to $35.00 and set a “hold” rating on the stock in a report on Monday, October 5th. Barclays cut their price target on Amrize from $55.00 to $40.00 and set an “equal weight” rating on the stock in a report on Monday, October 19th. Finally, UBS Group decreased their price target on Amrize from $57.00 to $42.00 and set a “neutral” rating for the company in a research note on Tuesday, September 22nd. Eight analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $49.29.

About Amrize

Amrize is a North American building-solutions company that supplies materials and products used in residential, commercial and infrastructure construction. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, roofing systems and other building products.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and related operations. Its products support applications ranging from roads, bridges and other public infrastructure to commercial buildings and residential construction.

Amrize was formed through the separation of Holcim’s North American business and began trading independently on the New York Stock Exchange under the symbol AMRZ in 2025.